Cost-effectiveness of linezolid vs vancomycin in suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia in Germany (Q43789991)

26 November 2017

Cost-effectiveness of linezolid vs vancomycin in suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia in Germany (English)

1 reference

methicillin-resistant Staphylococcus aureus

26 November 2017

0 references

0 references

1 reference

1 reference

1 reference

Staphylococcus aureus

1 reference

E De Cock

1

1 reference

26 November 2017

W A Krueger

2

1 reference

26 November 2017

S Sorensen

3

1 reference

26 November 2017

T Baker

4

1 reference

26 November 2017

J Hardewig

5

1 reference

26 November 2017

S Duttagupta

6

1 reference

26 November 2017

E Müller

7

1 reference

26 November 2017

A Piecyk

8

1 reference

26 November 2017

E Reisinger

9

1 reference

26 November 2017

A Resch

10

1 reference

26 November 2017

9 March 2009

1 reference

26 November 2017

1 reference

26 November 2017

37

1 reference

26 November 2017

123-132

1 reference

26 November 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/s15010-008-8046-7

26 November 2017

0 references

cites work

Cost-effectiveness analysis of the treatment of ventilator-associated pneumonia with linezolid or vancomycin in Spain

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS15010-008-8046-7

Cefepime versus imipenem-cilastatin for treatment of nosocomial pneumonia in intensive care unit patients: a multicenter, evaluator-blind, prospective, randomized study

21 January 2018

1 reference

12 December 2020

[Mortality in German intensive care units: dying from or with a nosocomial infection?]

1 reference

12 December 2020

Clinical cure and survival in Gram-positive ventilator-associated pneumonia: retrospective analysis of two double-blind studies comparing linezolid with vancomycin

1 reference

12 December 2020

Linezolid versus teicoplanin in the treatment of Gram-positive infections in the critically ill: a randomized, double-blind, multicentre study.

1 reference

12 December 2020

Stability of response characteristics of a Delphi panel: application of bootstrap data expansion

1 reference

12 December 2020

Nosocomial pneumonia: a cost-of-illness analysis

1 reference

12 December 2020

Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia

1 reference

12 December 2020

Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surve

1 reference

12 December 2020

Surveillance of nosocomial infections in intensive care units. Current data and interpretations

1 reference

12 December 2020

Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy

1 reference

12 December 2020

Comparison of linezolid with oxacillin or vancomycin in the empiric treatment of cellulitis in US hospitals

1 reference

12 December 2020

The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee

1 reference

12 December 2020

Mortality risk factors with nosocomial Staphylococcus aureus infections in intensive care units: results from the German Nosocomial Infection Surveillance System (KISS).

1 reference

12 December 2020

Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study

1 reference

12 December 2020

The Delphi methodology (Part one): A useful administrative approach

1 reference

12 December 2020

Cost-effectiveness of IV-to-oral switch therapy: azithromycin vs cefuroxime with or without erythromycin for the treatment of community-acquired pneumonia

1 reference

12 December 2020

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

1 reference

12 December 2020

Counterpoint: Vancomycin and Staphylococcus aureus--an antibiotic enters obsolescence

1 reference

12 December 2020

Linezolid compared with teicoplanin for the treatment of suspected or proven Gram-positive infections

1 reference

12 December 2020

1 reference

12 December 2020

The role of vancomycin in the treatment paradigm

1 reference

12 December 2020

Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus

1 reference

12 December 2020

The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges

1 reference

12 December 2020

Using the Delphi technique in economic evaluation: time to revisit the oracle?

1 reference

12 December 2020

Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis

1 reference

12 December 2020

Use of multistate models to assess prolongation of intensive care unit stay due to nosocomial infection

1 reference

12 December 2020

Economic evaluation of linezolid, flucloxacillin and vancomycin in the empirical treatment of cellulitis in UK hospitals: a decision analytical model

1 reference

12 December 2020

Nosocomial infections in combined medical-surgical intensive care units in the United States

1 reference

12 December 2020

Linezolid for treatment of ventilator-associated pneumonia: a cost-effective alternative to vancomycin

1 reference

12 December 2020

Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia

1 reference

12 December 2020

Prediction of poorer prognosis by infection with antibiotic-resistant gram-positive cocci than by infection with antibiotic-sensitive strains.

1 reference

12 December 2020

The Delphi methodology (Part Two): A useful administrative approach.

1 reference

12 December 2020

10.1007/S15010-008-8046-7

Identifiers

DOI

1 reference

release_tfxyccydgfdb7parzh2jetm554

26 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/tfxyccydgfdb7parzh2jetm554

24 November 2022

mapped directly with Wikidata item

1 reference